NA
ALHC icon

Navellier & Associates’s Alignment Healthcare ALHC Stock Holding History

Navellier & Associates’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,440
Closed -$360K – 323
2026
Q1 		$360K Sell
20,440
-592
-3% -$11.9K 0.04% 263
2025
Q4 		$415K Sell
21,032
-9,075
-30% -$163K 0.05% 243
2025
Q3 		$525K Buy
+30,107
New +$446K 0.05% 254

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Navellier & Associates's ALHC Position: Q2 2026 in Review

Navellier & Associates sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 20,440 shares — an estimated $360K sold.

Navellier & Associates first reported a position in ALHC in Q3 2025 and held it in 3 quarters. The position peaked at $525K in Q3 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Navellier & Associates reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Navellier & Associates sold 20,440 Alignment Healthcare shares in Q2 2026, an estimated $360K.
  • Navellier & Associates first reported a position in Alignment Healthcare in Q3 2025 and held it in 3 quarters.
  • Navellier & Associates's Alignment Healthcare position peaked at $525K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.